SUMO2 antibody (C-Term)
Quick Overview for SUMO2 antibody (C-Term) (ABIN783834)
Target
See all SUMO2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purification
- Affinity chromatography
-
Immunogen
- 15 amino acid peptide near the carboxy terminus of human SUMO2.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- SUMO2 (Small Ubiquitin Related Modifier 2 (SUMO2))
-
Alternative Name
- SUMO2
-
Background
- Small ubiquitin-like modifiers (SUMOs) are a family of small, related proteins (Sumo-1/2/3/4) that can be enzymatically attached to a target protein by a post-translational modification process termed sumoylation, which is a major regulator of protein function in cellular processes such as nuclear transport, transcriptional regulation, apoptosis and protein stability. All SUMO proteins localize to the nucleus and are covalently conjugated, affecting protein structure, function and interactions. SUMO2 and 3 are 96 % identical and are more mobile within nucleus relative to SUMO1. Specific functional differences between SUMO1 and SUMO2 and 3 remain to be identified.Synonyms: HSMT3, SMT3 homolog 2, SMT3B, SMT3H2, SUMO-2, Sentrin-2, Small ubiquitin-related modifier 2, Ubiquitin-like protein SMT3B
-
Gene ID
- 6613
-
NCBI Accession
- NP_001005849
-
UniProt
- P61956
-
Pathways
- Methionine Biosynthetic Process
Target
-